Citadel Group Limited Responds to ASX Queries

The Citadel Group Limited (ASX: CGL) is a leading services and software company with expertise in securing enterprise information management across health, defence, national security and corporate enterprises.

On 20th May 2019, ASX sent a letter with few queries to the company. On 22nd May 2019, the company released its response to the queries raised by ASX, which are as follows:

Sponsored ad by Kalkine

The first question asked to CGL was to confirm, if it is in compliance with the Listing Rules and especially, Listing Rule 3.1, keeping in mind the obligations of CGL under Listing Rules 3.1 and 3.1A and also to Guidance Note 8. In response to this ASX query, CGL confirmed that it is in compliance with the Listing Rules, particularly with Listing Rule 3.1.

The next question raised by ASX to CGL was regarding the Trading Update announcement released on the Market Announcements Platform on 17 May 2019.

The company had provided an update on the expected revenue as well as earnings for the FY2019 ending 30/06/2019. The company anticipated its revenues to be between $97 million to $104 million, the gross margin to decline by ~46%, and EBITDA to be in the range of $22 million to $24 million for the full year. The expected change in the FY19 revenues, as well as earnings, was reportedly due to delays in the commencement of customer-controlled project extensions and the company not experiencing an increase in customer spend as it did in the previous years.

ASX wanted to confirm whether CGL considers the information contained in the announcement to be the information that a sensible person would expect to have a material effect on the price or value of its securities. Responding to the question, CGL confirmed that the information provided by the company might have a material effect on the price or value of its securities.

Another question that was raised by ASX was regarding the time when the company first became aware of this information. In return, CGL responded that it became aware of this information upon completion of the April 2019 results, along with the full-year forecast based on current trading conditions that was presented to the Board after the closure of the trading session on 16th May 2019.

ASX also inquired about the reporting of Macquarie Presentation, where CGL was asked about the processes and procedures it undertook to ensure that the information contained in the Earnings Guidance provided by Mr Stanley in the Results Announcement did not require updating via a further announcement on the MAP. On the other hand, ASX also inquired about two bullet points regarding revenue and SaaS products, as to whether they were worded differently to the corresponding bullet points in the Half Year Presentation. As the company was aware at the time of the presentation that revenue and SaaS pipeline opportunities would not materialize in H2 FY2019 to the extent that was expected at the half-yearly results announcement, so ASX wanted to gain better clarity on what was the basis for rephrasing the two bullet points. In response, the company stated that the presentation was designed to highlight the products of the company as well as its pivot to the Citadel 2.0 strategy. As a result of this, the relevant slides were worded differently to the corresponding bullets points regarding revenue and SaaS products in H1 FY2019.

Since CGL’s listing on ASX, its shares have delivered a return of 83.11%. CGL closed the day’s trade at $4.300 on ASX (as on 22 May 2019), up 4.369% as compared to its previous closing price. CGL holds a market cap of $202.95 million and approximately 49.26 million outstanding shares.


Disclaimer

This website is a service of Kalkine Media Pty. Ltd. A.C.N. 629 651 672. The website has been prepared for informational purposes only and is not intended to be used as a complete source of information on any particular company. Kalkine Media does not in any way endorse or recommend individuals, products or services that may be discussed on this site. Our publications are NOT a solicitation or recommendation to buy, sell or hold. We are neither licensed nor qualified to provide investment advice.

Facebook Comments
Join Our Forum

We help you to connect with investors and people connected with the stock market.


6 Cannabis Stocks under Investor’s Limelight…

Cannabis companies that sell both medicinal weed and recreational pot. Marijuana stocks to look at. Marijuana mergers and acquisitions. Dispensary data analytics. Upcoming marijuana IPO’s Those phrases have become increasingly common as marijuana legalization spreads.

Global spending on legal cannabis is expected to grow 230% to $32 billion in 2020 as compared to $9.5 in 2017, according to Arcview Market Research and BDS Analytics. As of June 29, 2018 the United States Marijuana Index, despite a lot of uncertainty around regulations, has over the past 1 year gained 71.49%, as compared to about 12% gain seen by the S&P 500.

Click here for your FREE Report

LEAVE A REPLY

Please enter your comment!
Please enter your name here